aside
Merck Eprova and Isofol Medical Enter Exclusive Agreement for Merck Eprova’s Modufolin® in oncology
• Leucovorin has been a mainstay of colorectal cancer treatment for 50 years • Modufolin® may offer an improved profile…
by Admin Isofolaside
Cancer treatment with blockbuster potential
Investerarbolaget Yield med fokus på bolag i Göteborgsregionen har köpt in sig i medicinbolaget Isofol Medical AB. Yield har köpt…
by Admin Isofol